A Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Three Different Doses of Palonosetron Versus Placebo for Preventing Postoperative Nausea and Vomiting

Trial Profile

A Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Three Different Doses of Palonosetron Versus Placebo for Preventing Postoperative Nausea and Vomiting

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Aug 2008

At a glance

  • Drugs Palonosetron (Primary)
  • Indications Postoperative nausea and vomiting
  • Focus Registrational; Therapeutic Use
  • Sponsors Helsinn Healthcare SA
  • Most Recent Events

    • 05 Mar 2008 New trial record.
    • 02 Mar 2008 Primary endpoint 'Complete clinical response rate' has been met.
    • 02 Mar 2008 The US FDA has approved palonosetron for use in postoperative nausea and vomiting based on results from this study.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top